Iran Diabetes Care Devices Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook 2026-2030

Iran is home to approximately 92 million people, and diabetes represents a significant and growing public health challenge, with prevalence rates estimated among the highest in the Middle East region. The market for diabetes care devices in Iran includes blood glucose monitoring systems, continuous glucose monitoring (CGM) devices, insulin delivery systems, and related consumables. The sector operates within a unique environment shaped by economic sanctions, import restrictions, and a push toward domestic medical device manufacturing.

• •High diabetes prevalence drives sustained demand for monitoring and insulin delivery devices
• •Sanctions and import limitations have spurred domestic production of basic diabetes care products
• •The overall Iranian medical device market remains constrained by currency fluctuations and supply chain disruptions

Rising diabetes incidence, increasing obesity rates, and growing awareness of diabetes management among Iran's population are primary demand drivers for care devices. Government and healthcare system efforts to expand access to diabetes screening and management programs further stimulate market demand. Additionally, an aging population profile and the growing adoption of digital health technologies create momentum for more advanced devices.

• •Elevated diabetes prevalence sustained by lifestyle factors and genetic predispositions
• •Public health initiatives expanding diabetes screening and care access across regions
• •Increasing adoption of digital health platforms and telemedicine supporting remote diabetes management

Iran is divided into five geographic regions, and diabetes care device demand varies across these areas, with urban centers generally showing higher penetration of advanced monitoring technologies. Product-wise, blood glucose monitoring dominates the market, while CGM and insulin pump adoption remains comparatively limited due to cost and access barriers. The domestic manufacturing sector primarily focuses on blood glucose meters and test strips.

• •Blood glucose meters and test strips represent the largest product segment by volume
• •CGM and insulin pump segments remain niche due to higher costs and import dependency
• •Regional disparities in device access reflect differences in healthcare infrastructure across Iran's five regions

What are the recent trends and outlook?

Digital health integration, including smartphone-connected glucose monitors and tele-diabetes care platforms, is gradually entering the Iranian market despite infrastructure limitations. Domestic manufacturing capacity is expected to expand further as the country prioritizes medical self-sufficiency. Long-term growth will depend on geopolitical developments, sanction relief, and the ability of local producers to meet rising demand for more advanced device technologies.

• •Growing interest in connected glucose monitoring and mobile health applications among urban populations
• •Continued investment in local medical device manufacturing to reduce import reliance
• •Market trajectory remains closely tied to geopolitical and economic policy shifts affecting Iran's trade and healthcare sectors